Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 172

1.

Longitudinal testing of the Information-Motivation-Behavioral Skills model of self-care among adults with type 2 diabetes.

Meunier S, Coulombe S, Beaulieu MD, Côté J, Lespérance F, Chiasson JL, Bherer L, Lambert J, Houle J.

Patient Educ Couns. 2016 Jun 17. pii: S0738-3991(16)30276-2. doi: 10.1016/j.pec.2016.06.011. [Epub ahead of print]

PMID:
27373961
2.

Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During Exercise.

Taleb N, Emami A, Suppere C, Messier V, Legault L, Chiasson JL, Rabasa-Lhoret R, Haidar A.

Diabetes Technol Ther. 2016 Sep;18(9):561-7. doi: 10.1089/dia.2015.0394. Epub 2016 Jun 29.

PMID:
27356172
3.

Socioeconomic status and glycemic control in adult patients with type 2 diabetes: a mediation analysis.

Houle J, Lauzier-Jobin F, Beaulieu MD, Meunier S, Coulombe S, Côté J, Lespérance F, Chiasson JL, Bherer L, Lambert J.

BMJ Open Diabetes Res Care. 2016 May 11;4(1):e000184. doi: 10.1136/bmjdrc-2015-000184. eCollection 2016.

4.

No effects of pantoprazole on the pharmacokinetics of rosuvastatin in healthy subjects.

Huguet J, Lu J, Gaudette F, Chiasson JL, Hamet P, Michaud V, Turgeon J.

Eur J Clin Pharmacol. 2016 Aug;72(8):925-31. doi: 10.1007/s00228-016-2065-6. Epub 2016 May 5.

PMID:
27146814
5.

Response to Comment on Tang et al. Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial. Diabetes Care 2015;38:1339-1346.

Tang A, Rabasa-Lhoret R, Castel H, Wartelle-Bladou C, Gilbert G, Massicotte-Tisluck K, Chartrand G, Olivié D, Julien AS, de Guise J, Soulez G, Chiasson JL.

Diabetes Care. 2015 Sep;38(9):e150-1. doi: 10.2337/dc15-1091. No abstract available.

PMID:
26294785
6.

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes.

Everett BM, Brooks MM, Vlachos HE, Chaitman BR, Frye RL, Bhatt DL; BARI 2D Study Group.

N Engl J Med. 2015 Aug 13;373(7):610-20. doi: 10.1056/NEJMoa1415921.

7.

7A.02: CARDIOMYOPATHY IN OBESE AND DIABETIC MALE DB/DB MICE IS INHIBITED BY OXYTOCIN TREATMENT.

Jankowski M, Plante E, Menaouar A, Chiasson JL, Gutkowska J.

J Hypertens. 2015 Jun;33 Suppl 1:e89. doi: 10.1097/01.hjh.0000467589.04230.8a.

PMID:
26102958
8.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group.

N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. Erratum in: N Engl J Med. 2015 Aug 6;373(6):586.

9.

Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial.

Tang A, Rabasa-Lhoret R, Castel H, Wartelle-Bladou C, Gilbert G, Massicotte-Tisluck K, Chartrand G, Olivié D, Julien AS, de Guise J, Soulez G, Chiasson JL.

Diabetes Care. 2015 Jul;38(7):1339-46. doi: 10.2337/dc14-2548. Epub 2015 Mar 26.

PMID:
25813773
10.

Glycaemic control and self-management behaviours in Type 2 diabetes: results from a 1-year longitudinal cohort study.

Houle J, Beaulieu MD, Chiasson JL, Lespérance F, Côté J, Strychar I, Bherer L, Meunier S, Lambert J.

Diabet Med. 2015 Sep;32(9):1247-54. doi: 10.1111/dme.12686. Epub 2015 Jan 27.

PMID:
25581545
11.

Oxytocin treatment prevents the cardiomyopathy observed in obese diabetic male db/db mice.

Plante E, Menaouar A, Danalache BA, Yip D, Broderick TL, Chiasson JL, Jankowski M, Gutkowska J.

Endocrinology. 2015 Apr;156(4):1416-28. doi: 10.1210/en.2014-1718. Epub 2015 Jan 6.

PMID:
25562615
12.

Glycaemic control, cardiovascular disease, and mortality in type 2 diabetes.

Chiasson JL, Le Lorier J.

Lancet. 2014 Nov 29;384(9958):1906-7. doi: 10.1016/S0140-6736(14)60884-9. Epub 2014 Jul 31. No abstract available.

PMID:
25088436
13.

All-trans retinoic acid stimulates gene expression of the cardioprotective natriuretic peptide system and prevents fibrosis and apoptosis in cardiomyocytes of obese ob/ob mice.

Manolescu DC, Jankowski M, Danalache BA, Wang D, Broderick TL, Chiasson JL, Gutkowska J.

Appl Physiol Nutr Metab. 2014 Oct;39(10):1127-36. doi: 10.1139/apnm-2014-0005. Epub 2014 Apr 30.

PMID:
25017112
14.

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial.

Holman RR, Bethel MA, Chan JC, Chiasson JL, Doran Z, Ge J, Gerstein H, Huo Y, McMurray JJ, Ryden L, Liyanage W, Schröder S, Tendera M, Theodorakis MJ, Tuomilehto J, Yang W, Hu D, Pan C; ACE Study Group.

Am Heart J. 2014 Jul;168(1):23-9.e2. doi: 10.1016/j.ahj.2014.03.021. Epub 2014 Apr 5.

PMID:
24952856
15.

Estimating the population prevalence of diagnosed and undiagnosed diabetes.

Leong A, Dasgupta K, Chiasson JL, Rahme E.

Diabetes Care. 2013 Oct;36(10):3002-8. doi: 10.2337/dc12-2543. Epub 2013 May 8.

16.

Efficacy and safety of taspoglutide versus sitagliptin for type 2 diabetes mellitus (T-emerge 4 trial).

Bergenstal RM, Forti A, Chiasson JL, Woloschak M, Boldrin M, Balena R.

Diabetes Ther. 2012 Dec;3(1):13. doi: 10.1007/s13300-012-0013-8. Epub 2012 Nov 9.

17.

Strategies for multivessel revascularization in patients with diabetes.

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators.

N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.

18.

Conversion of IGT to type 2 diabetes mellitus is associated with incident cases of hypertension: a post-hoc analysis of the STOP-NIDDM trial.

Hanefeld M, Pistrosch F, Koehler C, Chiasson JL.

J Hypertens. 2012 Jul;30(7):1440-3. doi: 10.1097/HJH.0b013e328354663c.

PMID:
22573126
19.

Estimating insulin secretion in youth using simple indices derived from the oral glucose tolerance test.

Henderson M, Baillargeon JP, Rabasa-Lhoret R, Chiasson JL, Hanley J, Lambert M.

Diabetes Metab. 2012 Oct;38(4):309-15. doi: 10.1016/j.diabet.2012.02.002. Epub 2012 Mar 23.

20.

Altering source or amount of dietary carbohydrate has acute and chronic effects on postprandial glucose and triglycerides in type 2 diabetes: Canadian trial of Carbohydrates in Diabetes (CCD).

Wolever TM, Gibbs AL, Chiasson JL, Connelly PW, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA.

Nutr Metab Cardiovasc Dis. 2013 Mar;23(3):227-34. doi: 10.1016/j.numecd.2011.12.011. Epub 2012 Mar 6.

PMID:
22397878
Items per page

Supplemental Content

Loading ...
Write to the Help Desk